NCT04189952 2025-05-31Acalabrutinib in Combination With R-ICE For Relapsed or Refractory LymphomaUniversity of MiamiPhase 2 Terminated2 enrolled 6 charts
NCT04933617 2024-07-09Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Terminated8 enrolled 17 charts
NCT00788125 2023-07-14Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsCity of Hope Medical CenterPhase 1/2 Terminated7 enrolled 9 charts
NCT00482053 2018-05-14Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCTStanford UniversityPhase 2 Terminated3 enrolled 13 charts